Skip to main content
. Author manuscript; available in PMC: 2010 Nov 11.
Published in final edited form as: Clin Oncol (R Coll Radiol). 2010 Nov;22(9):755–763. doi: 10.1016/j.clon.2010.08.001

Table 2.

Summary data from randomised studies of surgery versus endoscopic stenting of malignant biliary obstruction

Reference Number of patients in each group Therapeutic success Complications 30 day mortality Recurrent obstruction Median length of hospital stay (days)
[33] Surgery 101 92% Major 29% 15% 2% 26
Endoscopic 100 92% 11% 8% 36% 9
(P = 0.02) (NS) (NS) (NS)
Minor 29%
18%
(NS)
[34] Surgery 25 88% 20% 24% NR 27
Endoscopic 25 96% 36% 20% NR 26
(NS) (NS) (NS)
[35] Surgery 25 92% 56% 20% 0% 13
Endoscopic 23 91% 30% 9% 43% 5
(NS) (NS) (P < 0.002)